Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Deloitte
Cantor Fitzgerald
Cipla
Baxter
Moodys
Julphar
Colorcon
Mallinckrodt
Federal Trade Commission

Generated: January 19, 2018

DrugPatentWatch Database Preview

PALIPERIDONE Drug Profile

« Back to Dashboard

Which patents cover Paliperidone, and when can generic versions of Paliperidone launch?

Paliperidone is a drug marketed by Actavis Labs Fl Inc and Mylan Pharms Inc and is included in two NDAs.

The generic ingredient in PALIPERIDONE is paliperidone. There are thirty-five drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the paliperidone profile page.
Drug patent expirations by year for PALIPERIDONE
Pharmacology for PALIPERIDONE

US Patents and Regulatory Information for PALIPERIDONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE;ORAL 202645-001 Aug 3, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE;ORAL 203802-003 Sep 24, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Fl Inc PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE;ORAL 202645-004 Aug 3, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE;ORAL 203802-004 Sep 24, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Fl Inc PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE;ORAL 202645-002 Aug 3, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Fl Inc PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE;ORAL 202645-003 Aug 3, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE;ORAL 203802-002 Sep 24, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE;ORAL 203802-001 Sep 24, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
QuintilesIMS
Covington
Fuji
Teva
Johnson and Johnson
Cantor Fitzgerald
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot